Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Peptide and Protein Research
|
August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation
K F Fok, S G Panzer-Knodle, N S Nicholson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis
L P Feigen, N S Nicholson, L W King, et al.
Platelets
|
November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa
S G Panzer-Knodle, P Jacqmin, J D Page, et al.
Journal of Medicinal Chemistry
|
June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
J A Zablocki, M Miyano, R B Garland, et al.
Thrombosis Research
|
June 1, 1994
SC-49992--a potent and specific inhibitor of platelet aggregation
N S Nicholson, S G Panzer-Knodle, L W King, et al.
American Heart Journal
|
May 20, 1998
Assessment of platelet function assays
N S Nicholson, S G Panzer-Knodle, N F Haas, et al.
Thrombosis Research
|
June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Circulation
|
January 15, 1995
SC-54684A: an orally active inhibitor of platelet aggregation
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Medicinal Research Reviews
|
April 13, 2001
Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist
N S Nicholson, N A Abood, S G Panzer-Knodle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Peptide and Protein Research
|
August 1, 1991
Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation
K F Fok, S G Panzer-Knodle, N S Nicholson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosis
L P Feigen, N S Nicholson, L W King, et al.
Platelets
|
November 4, 2010
Characterization of Binding of an RGD Mimetic, [(3)H]-SC-52012, to Platelet GPIIb/IIIa
S G Panzer-Knodle, P Jacqmin, J D Page, et al.
Journal of Medicinal Chemistry
|
June 25, 1993
Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor
J A Zablocki, M Miyano, R B Garland, et al.
Thrombosis Research
|
June 1, 1994
SC-49992--a potent and specific inhibitor of platelet aggregation
N S Nicholson, S G Panzer-Knodle, L W King, et al.
American Heart Journal
|
May 20, 1998
Assessment of platelet function assays
N S Nicholson, S G Panzer-Knodle, N F Haas, et al.
Thrombosis Research
|
June 1, 1991
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Circulation
|
January 15, 1995
SC-54684A: an orally active inhibitor of platelet aggregation
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1991
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749)
N S Nicholson, S G Panzer-Knodle, A K Salyers, et al.
Medicinal Research Reviews
|
April 13, 2001
Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist
N S Nicholson, N A Abood, S G Panzer-Knodle, et al.
Page
of 1